|
|
|
Insider
Information: |
Haskel William M. |
Relationship: |
CLO, General Counsel &... |
City: |
East Rutherford |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
0 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
50.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cambrex Corp |
CBM |
Senior Vice President |
2014-11-13 |
0 |
2014-08-06 |
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
CLO, General Counsel &... |
2023-09-21 |
0 |
2015-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2015-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2018-12-13 |
4 |
AS |
$6.25 |
$6,250 |
D/D |
(1,000) |
98,551 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2018-02-05 |
4 |
AS |
$14.22 |
$15,372 |
D/D |
(1,081) |
35,458 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2019-02-05 |
4 |
AS |
$6.77 |
$9,011 |
D/D |
(1,331) |
112,220 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2018-10-15 |
4 |
AS |
$8.96 |
$19,990 |
D/D |
(2,231) |
102,683 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2017-07-05 |
4 |
AS |
$23.58 |
$58,027 |
D/D |
(2,461) |
36,539 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2019-12-12 |
4 |
S |
$3.10 |
$8,878 |
D/D |
(2,864) |
158,356 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2018-12-12 |
4 |
AS |
$6.76 |
$21,172 |
D/D |
(3,132) |
99,551 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2018-04-09 |
4 |
AS |
$12.70 |
$42,685 |
D/D |
(3,361) |
69,597 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CLO, General Counsel & Sec. |
|
2022-10-28 |
4 |
AS |
$3.47 |
$15,206 |
D/D |
(4,382) |
437,801 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2020-05-12 |
4 |
S |
$4.75 |
$22,164 |
D/D |
(4,666) |
198,690 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CLO, General Counsel & Sec. |
|
2020-12-11 |
4 |
AS |
$6.95 |
$33,457 |
D/D |
(4,814) |
210,109 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CLO, General Counsel & Sec. |
|
2021-12-13 |
4 |
AS |
$4.42 |
$21,552 |
D/D |
(4,876) |
365,649 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2018-10-03 |
4 |
AS |
$9.82 |
$57,545 |
D/D |
(5,860) |
98,914 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2018-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
104,914 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CLO, General Counsel & Sec. |
|
2020-12-14 |
4 |
AS |
$6.71 |
$45,910 |
D/D |
(6,842) |
203,267 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CLO, General Counsel & Sec. |
|
2020-11-13 |
4 |
AS |
$5.93 |
$40,870 |
D/D |
(6,892) |
214,923 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
39,000 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CLO, General Counsel & Sec. |
|
2022-12-21 |
4 |
AS |
$1.99 |
$13,944 |
D/D |
(7,007) |
407,800 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
Sr. VP, Sec. & General Counsel |
|
2018-07-02 |
4 |
AS |
$9.97 |
$73,010 |
D/D |
(7,323) |
62,274 |
0 |
- |
|
CBM |
Cambrex Corp |
Senior Vice President |
|
2014-11-13 |
4 |
OE |
$16.91 |
$126,788 |
D/D |
7,500 |
7,500 |
0 |
- |
|
CBM |
Cambrex Corp |
Senior Vice President |
|
2014-11-13 |
4 |
S |
$23.97 |
$179,972 |
D/D |
(7,500) |
0 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
CLO, General Counsel & Sec. |
|
2021-06-04 |
4 |
AS |
$9.70 |
$73,342 |
D/D |
(7,561) |
357,092 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CLO, General Counsel & Sec. |
|
2021-12-14 |
4 |
AS |
$4.37 |
$36,323 |
D/D |
(8,312) |
357,337 |
0 |
% |
|
PRTK |
Paratek Pharmaceuticals I... |
CLO, General Counsel & Sec. |
|
2022-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,250 |
442,183 |
0 |
- |
|
57 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|